Maintenance IV immunoglobulin treatment in chronic inflammatory demyelinating polyradiculoneuropathy-Reference-Cited by-同舟云学术

Maintenance IV immunoglobulin treatment in chronic inflammatory demyelinating polyradiculoneuropathy

Published:2017-11-21 Issue:4 Volume:22 Page:425-432
ISSN:1085-9489
Container-title:Journal of the Peripheral Nervous System
language:en
Short-container-title:J Peripher Nerv Syst

Author:

Kuitwaard Krista¹²,Fokkink Willem-Jan R.¹³,Brusse Esther¹,Vrancken Alexander F. J. E.⁴,Eftimov Filip⁵,Notermans Nicolette C.⁴,van der Kooi Anneke J.⁵,Merkies Ingemar S. J.⁶⁷,Jacobs Bart C.¹³,van Doorn Pieter A.¹

Affiliation:

1. Department of Neurology; Erasmus MC University Medical Center; Rotterdam The Netherlands

2. Department of Neurology; Albert Schweitzer Hospital; Dordrecht The Netherlands

3. Department of Immunology; Erasmus MC University Medical Center; Rotterdam The Netherlands

4. Department of Neurology; Brain Center Rudolf Magnus University, Medical Center Utrecht; Utrecht The Netherlands

5. Department of Neurology; Academic Medical Center; Amsterdam The Netherlands

6. Department of Neurology, School of Mental Health and Neuroscience; Maastricht University Medical Center; Maastricht The Netherlands

7. Department of Neurology; St. Elisabeth Hospital; Willemstad Curacao

Publisher

Wiley

Subject

Neurology (clinical),General Neuroscience

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1111/jns.12242/fullpdf

Reference69 articles.

1. Intravenous immunoglobulin treatment in chronic inflammatory demyelinating polyradiculoneuropathy, a time to start and a time to stop;Adrichem;J Peripher Nerv Syst,2016

2. Intravenous immunoglobulin (IVIG) treatment-related fluctuations in chronic inflammatory demyelinating polyneuropathy (CIDP) patients using daily grip strength measurements (GRIPPER): study design and progress update;Allen;J Peripher Nerv Syst,2017

3. IVIg dose increase in multifocal motor neuropathy: a prospective six month follow-up;Baumann;J Neurol,2009

4. Subcutaneous immunoglobulin replacement in primary immunodeficiencies;Berger;Clin Immunol,2004

5. Subcutaneous IgG in neurologic diseases;Berger;Immunotherapy,2014

Cited by 24 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Current clinical management of CIDP with immunoglobulins in France: An expert opinion;Revue Neurologique;2023-10

2. Standardized Tapering off Subcutaneous Immunoglobulin in Chronic Inflammatory Demyelinating Polyneuropathy;Journal of Neuromuscular Diseases;2023-09-08

3. Fatigue, depression, and product tolerability during long-term treatment with intravenous immunoglobulin (Gamunex® 10%) in patients with chronic inflammatory demyelinating polyneuropathy;BMC Neurology;2023-05-26

4. Randomized trial of three IVIg doses for treating chronic inflammatory demyelinating polyneuropathy;Brain;2022-01-17

5. Progress in Treatment of Chronic Inflammatory Demyelinating Polyradiculoneuropathy;Advances in Clinical Medicine;2022